O-GlcNAcase-IN-3
O-GlcNAcase-IN-3 (Compound I) is an OGA inhibitor. O-GlcNAcase-IN-3 can be used for Alzheimer's Disease (AD) research[1].
Product Specifications
CAS Number
2760514-33-6
UNSPSC
12352005
Target
OGA
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Smiles
COC1=NC=NC(O[C@@H]2C[C@H](C)N(CC3=C(F)N=C(NC(C)=O)S3)C2)=C1.O[C@H]([C@@H](O)C(O)=O)C(O)=O
Molecular Formula
C20H26FN5O9S
Molecular Weight
531.51
References & Citations
[1]NERY O'DONNELL F C, et al. N-[4-fluor-5-[[ (2s, 4 r) -4-[ (6-methoxy-4-pyrimidinyl) oxy]- 2-methyl-1-pyrrolidinyl] methyl ]-2-thiazolyl]acetamid for use in the treatment of alzheimer disease. WO2025184490A1. 2025-09-04.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E13232r 96 Tests
ELISA Kit For Phosphoribosyl pyrophosphate synthase-associated protein 2
Sign In for Pricing
View Details 
NBP3-12048PCP 0.1 mL
Rabbit Monoclonal MARCO Antibody (PLK1) [PerCP]
Sign In for Pricing
View Details 